Meiselbach is alllll over the place. That's good and bad. Looks like a good network, not great. But this dude will not be well focused on us, and I don't see a lot of results. He's also been an advisor for us for almost 2 years now.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links